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INTRODUCTION
Trefoil factor family (TFF) peptides are involved in the 
maintenance of epithelial integrity and epithelial restitution. 
TFF3 peptide is found in the epithelia of various human organ 
systems. The main site of TFF3 peptide expression is gastroin-
testinal mucosa, where it is excreted from the granules together 
with mucins onto the epithelial surface, which contributes to 
the formation of the protective mucosal layer [1,2]. Following 
mucosal injury, TFF peptides act as motogens by reducing cell-
cell and cell-surface contacts [3]. Antiapoptotic and pro-an-
giogenic effects of TFF3 peptide have been described [4,5], as 
well as its effect on the immune system [6,7].
TFF3 peptide is involved in regeneration of epithelial inju-
ries in the digestive system, and it stimulates the differentiation 
of ciliated cells, which is important in maintaining the normal 
function of the respiratory system [8]. In the urinary system, 
TFF3 peptide is found in the kidney tissue and is assumed to 
play an important role in repairing the damage of kidney tubu-
lar epithelium [9]. TFF3 peptide is also found in the epithe-
lia of several other organs (e.g. eye, inner ear, uterus, mucous 
glands, pancreas, liver, breast, etc.) [10-12], as well as in urine, 
serum, amniotic fluid, and breast milk [13]. In addition, TFF3 
peptide was detected in the nervous system and some avascu-
lar tissues [14,15].
The localization and function of TFF3 peptide have been 
monitored in different pathological conditions. A number of 
studies identified the oncogenic potential of TFF3 peptide. 
Higher TFF3 peptide levels in the serum were associated with 
a more malignant form of tumor, existence of distant metas-
tases, and a worse prognosis for patients with colon, stomach, 
and breast tumors [16-18]. TFF3 peptide is assumed to stimu-
late the proliferation of tumor cells, extend the survival, and 
facilitate their migration, which results in the formation of 
distant metastases [17]. TFF3 peptide was also investigated in 
the context of inflammatory bowel disease and shown to have 
a role in protection and repair of the epithelium [19,20]. In 
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ABSTRACT
Trefoil factor family (TFF) peptides are involved in the maintenance of epithelial integrity and epithelial restitution. Mature epithelial tissues 
originate from different embryonic germ layers. The objective of this research was to explore the presence and localization of TFF3 peptide in 
mouse embryonic epithelia and to examine if the occurrence of TFF3 peptide is germ layer-dependent. Mouse embryos (14-18 days old) were 
fixed in 4% paraformaldehyde and embedded in paraffin. Immunohistochemistry was performed with affinity purified rabbit anti-TFF3 antibody, 
goat anti-rabbit biotinylated secondary antibody and streptavidin-horseradish peroxidase, followed by 3,3’-diaminobenzidine. TFF3 peptide was 
present in the gastric and intestinal mucosa, respiratory mucosa in the upper and lower airways, pancreas, kidney tubules, epidermis, and oral 
cavity. The presence and localization of TFF3 peptide was associated with the embryonic stage and tissue differentiation. TFF3 peptide distribu-
tion specific to the germ layers was not observed. The role of TFF3 peptide in cell migration and differentiation, immune response, and apoptosis 
might be associated with specific embryonic epithelial cells. TFF3 peptide may also be considered as a marker for mucosal maturation.
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addition, local and systematic application of TFF dimers miti-
gates the course of ulcerous colitis [21]. Recent research shows 
that TFF3 peptide levels are increased during inflammatory 
processes of the respiratory system, such as chronic obstruc-
tive pulmonary disease and asthma [22].
In spite of continuous research, the exact molecular mech-
anism of TFF3 peptide in the restitution and regeneration of 
gastric mucosa is still unclear [23]. TFF3 peptide acts through 
various signaling cascades in cells [24]. The peptide stimulates 
the activation of extracellular signal-regulated kinase/mito-
gen-activated protein kinase and activates serine phosphory-
lation of Akt, a kinase associated with apoptotic pathways [25]. 
Intestinal restitution induced by TFF3 peptide is also con-
nected with IL-6/Gp130/STAT signaling [26]. TFF3 peptide 
activates STAT3 [27] that exerts anti-apoptotic and mitogenic 
effects [28]. It modulates the E-cadherin/catenin cell adhesion 
complex in various ways. For example, exogenous TFF3 pep-
tide in HT-29 cells reduces the level of E-cadherin, β-catenin, 
α-catenin and the adenomatous polyposis coli (APC) protein, 
leading to significant alterations in cell aggregation, detach-
ment from the substratum, and translocation of APC from the 
cytoplasm to nucleus [29].
Mature epithelial tissues originate from all three embry-
onic germ layers. Ectodermal derivatives are epidermis and 
cutaneous appendages, as well as olfactory and mouth epithe-
lium. The epithelium of the pelvicalyceal system and ureters 
and epithelium of the kidney collecting duct system and renal 
tubules (nephrons) differentiate from the intermediate meso-
derm. Endothelium and mesothelium originate from the lat-
eral plate mesoderm. Endoderm-derived epithelium lines the 
digestive tube, trachea, bronchi, lungs, tympanic cavity, audi-
tory tube, urinary bladder, and urethra. In addition, epithelial 
cells in the liver, gallbladder, pancreas, thymus, thyroid gland 
and parathyroids also develop from the endoderm [30].
All or individual TFF peptides have been reported in 
the embryonic nervous and gastrointestinal system, as well 
as in the process of endochondral ossification in the mouse 
embryos [31-35]. However, no systematic overview of TFF 
peptide expression in embryonic tissue was published to date. 
The objective of this study was to explore the presence and 
localization of TFF3 peptide in mouse embryonic epithelia 
and to examine if the occurrence of TFF3 peptide is germ 
layer-dependent.
MATERIALS AND METHODS
CD1 mouse embryos, 14, 15, 16, 17 and 18  days old, were 
taken from the 4% paraformaldehyde fixed and paraffin-em-
bedded embryonic sample collection of the Department of 
Histology and Embryology, Faculty of Medicine Osijek. The 
research has been approved by the local Ethical Committee 
(Faculty of Medicine Osijek) and supported by Ministry 
of Science, Education and Sports of the Republic of Croatia 
(Grant no. 219-0982914-2179).
The embryos in the collection were obtained from dams 
on a specific gestational day, following cervical dislocation. 
Overall, 23 mouse embryos were used (3-6 per stage, due 
to a varying number of embryos per pregnancy and the fact 
that a few embryos were excluded for inadequate fixation). 
The paraffin blocks were cut on a microtome (Reichert-Jung 
2400, Vienna, Austria) into 6 μm sagittal sections, placed on 
adhesive Menzel-Gläser Polysine slides (Thermo Scientific, 
Rockford, USA) or equivalent.
Slides were deparaffinized and rehydrated using 100% 
xylene, 100%, 96%, and 70% ethanol and tap water. Peroxidase 
block was performed using 0.3% hydrogen peroxide for 15 min-
utes, after which antigen retrieval was done by microwave 
heating in citrate buffer (pH 6) for 3-5 minutes. Non-specific 
binding was blocked with SuperBlock solution (Thermo 
Scientific, Rockford, SAD) for at least 30  minutes. Affinity-
purified polyclonal rabbit anti-TFF3 antibody was used (dilu-
tion 1:5000) for overnight incubation at 4°C. Specificity of the 
primary antibody was tested on TFF3 knockout mouse intes-
tine where no staining was found. Detection system specific-
ity was tested by omitting primary antibody. Wild-type mouse 
intestine was used as the positive control. The antibody has 
been raised against a specific epitope comprising the last 15 
amino acid (AA) positions (45-59) [VPWCFKPLQEA ECTF].
After primary antibody incubation, the slides were repeat-
edly rinsed in phosphate buffered saline (PBS) with 0.05% 
Tween (Sigma-Aldrich, St. Louis; MO, SAD). Following the 
rinsing, biotinylated goat anti-rabbit antibody (Dako, Glostrup, 
Denmark) was used as a secondary layer, dilution 1:300 for 
30  minutes. Rinsing in PBS was repeated, and then strepta-
vidin-horseradish peroxidase (Dako or Sigma-Aldrich) was 
applied in 1:300 dilution for another 30  minutes. Following 
another rinsing series, immunocomplexes were visualized 
with 3,3’-diaminobenzidine solution (Sigma-Aldrich or 
Vector Laboratories, Burlingame, CA, USA). After another 
series of rinsing in PBS, the slides were counterstained with 
hemalaun, rinsed in tap water, dehydrated and permanent 
slides were made using Canada balsam. Olympus C-5050 
digital camera mounted on an Olympus BX-50 microscope 
(Olympus, Tokyo, Japan) was used for taking digital photo-
graphs with the QuickPHOTO Pro software (Promicra s.r.o, 
Prague, Czech Republic).
RESULTS
Gastrointestinal mucosa
TFF3 peptide was differently distributed along the gastro-
intestinal tract, depending on the gestational day.
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In the oral cavity, mild to moderate signal intensity for 
TFF3 peptide was observed in stratified squamous epithe-
lium, in the five monitored embryonic stages (Figure  1A). 
The sections of the developing teeth showed the presence of 
TFF3 peptide in the cells of both epithelial and mesenchymal 
origin; for example, TFF3 signal was observed in the stellate 
reticulum, odontoblasts, and enamel epithelium (Figure  1B). 
Although still visible, TFF3 signal in the oral cavity was the 
weakest on embryonic day 14 (E14).
In the gastric mucosa, weak or no immunostaining was 
detected in E14 and E15 stages (Figure 1C). In E16 stage, TFF3 
signal was observed in several sections, while in E17 and E18 
stages it was clearly visible in all sections, especially in the non-
glandular stomach (Figure 1D). On the other hand, in the glan-
dular stomach, the signal was weak or missing (data not shown).
In the small intestine, TFF3 signal was absent in E14 stage, 
mild signal intensity was detected in E15 stage (Figure 1E), and 
a strong TFF3 signal, typical for the goblet cells, was observed 
in E16 to E18 stages (Figure 1F), comparable to the results for 
the adult intestinal mucosa. Similar pattern of TFF3 signal 
intensity was seen in the colon, except in the E16 stage; in 
some cases, the goblet cells were not completely differenti-
ated, thus the signal was not consistent in all sections. A strong 
TFF3 signal was observed in all stages where the goblet cells 
were clearly differentiated, especially in E17 and E18 stages 
(Figure 1G). In the rectum, TFF3 signal was strong in the later 
stages (i.e., E17 and E18).
The pancreatic acinar cells were negative for TFF3 peptide, 
while the positive signal was detected in the tissue between 
acinar cell areas, which might correspond to pancreatic islets 
of Langerhans (Figure 1H). TFF3 signal was present to some 
extent in the liver, but was not distributed homogenously. The 
salivary glands were mostly negative for TFF3 peptide, except 
for the ducts, where moderate TFF3 signal intensity was occa-
sionally observed.
Respiratory system
The nasal respiratory epithelium was TFF3-positive, espe-
cially in the embryos in E16 to E18 stages (Figure 2A). The signal 
was mostly present in the goblet cells and on the surface of cili-
ated cells (cilia). In embryos 14 and 15 days old, mild TFF3 sig-
nal intensity was sporadically detected (i.e., not in all sections). 
Similar results were obtained for the lungs (Figure 2B and C). 
For example, in the lungs, TFF3 peptide was mostly localized 
in the respiratory epithelium of the bronchi and bronchioles, 
in E17 and E18 stages. TFF3 signal was not observed in small 
bronchiolar branches. Similarly, TFF3 signal was not detected 
in the earlier embryonic stages (i.e. E14-E16), except for a weak 
signal in several sections.
Urinary system
A moderate to strong signal was detected in the developing 
kidney tubules. Although TFF3 signal was detected to some 
extent in E14 stage, a weak TFF3 signal was present mostly 
from E15 stage onward (Figure 2D). TFF3 immunostaining was 
predominantly visible in the cortical tubules, which morpho-
logically correspond to proximal and distal convoluted tubules. 
It was also present in some of the medullary tubules, morpho-
logically corresponding to the thick limb of the Henle’s loop 
and collecting ducts. Tubules originating from renal vesicles 
showed stronger staining for TFF3 peptide than the collecting 
FIGURE 1. Localization of trefoil factor family 3 (TFF3) peptide in 
the mouse embryonic gastrointestinal system. (A) TFF3 peptide 
signal in the stratified squamous epithelium of the oral cavity; 
16-day-old mouse embryo. (B) Odontoblasts (arrow heads) and 
enamel epithelium (arrow) positive for TFF3 peptide in a devel-
oping tooth of an 18-day-old mouse embryo. (C) Discrete TFF3 
peptide signal in the undifferentiated endodermal epithelium of 
the gastric mucosa; 15-day-old mouse embryo. (D) TFF3 peptide 
staining in the differentiated nonglandular stomach of an 18-day-
old embryo. (E) Scattered TFF3 peptide signal in the endoder-
mal epithelium undergoing differentiation in the small intestine; 
15-day-old mouse embryo. (F) Localization of TFF3 peptide in 
the differentiated goblet cells of the small intestine of a 17-day-
old mouse embryo. (G) Strong TFF3 staining in the differentiated 
goblet cells of the colonic mucosa; 17-day-old mouse embryo. 
(H) TFF3 peptide present in the tissue between the exocrine 
acini, probably developing islets of Langerhans. Scale bar: 60 µm, 
except for (D) 100 µm.
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ducts. The glomeruli were negative for TFF3 peptide in all 
development stages, as well as the sections of the developing 
structures of the nephrogene zone. Similarly, the urinary blad-
der sections were negative for TFF3 peptide, with only mild 
signal intensity observed on several sections, which was proba-
bly the experimental artifact (weak background staining).
The skin and sensory organs
In E14 and E15 stages, the typical epidermal layer structure 
was still not visible, while in E16, and especially in E17 and E18 
stages, the epidermal layers were completely formed, which 
was in line with the normal embryonic development. A mild 
to moderate, diffuse TFF3 signal was observed in the devel-
oping epidermis, in E14 and E15 stages (Figure  2E). As the 
epidermal layers formed, the signal became confined to the 
epidermal layers that are in the middle (i.e., stratum spinosum 
and stratum granulosum), while occurring only occasionally 
in stratum corneum, in E18 stage (Figure 2F). Stratum basale 
was negative for TFF3 peptide in almost all sections. The cells 
in the hair follicles were also positive for TFF3 peptide. The 
distribution of TFF3-positive cells in the hair follicles was 
the same as in the epidermis. No TFF3 immunostaining was 
detected in the dermis.
TFF3 was detected in the corneal and conjunctival epithe-
lium and lens (Figure 2G), as well as in the retina and optical 
nerve (data not shown). The signal was moderate in E14 to 
E16 stages, mild to moderate in E17 and E18 stages, and was 
not always consistent in all sections. TFF3 was also detected 
in the inner ear (Figure 2H), particularly in the neurons of spi-
ral ganglion and in the epithelium covering various portions 
of membranous labyrinth, mostly cochlea and semicircular 
ducts. The crista ampullaris was observed on several sections 
and showed a weak TFF3 signal. Sensory nerve fibers coming 
from the ganglia of the inner ear showed a mild and diffuse 
signal. The remaining part of the labyrinth, including the con-
nective tissue and cartilage were negative for TFF3 peptide.
Positive and negative controls are presented in Figure 3.
DISCUSSION
Our results showed that TFF3 peptide was present in dif-
ferent epithelial tissues of developing mouse embryo, from E14 
to E18 stages. The intensity of the immunostaining in some tis-
sues depended on the developmental stage. TFF3 peptide-ex-
pressing tissues originated from all three germ layers, namely, 
ectoderm (epidermis, sensory epithelium), mesoderm (kid-
ney tubules), and endoderm (respiratory and gastrointestinal 
mucosa), therefore, TFF3 peptide expression in embryonic 
epithelial tissues is probably not embryonic layer-dependent.
Otto and Patel [35] showed by means of in situ hybridiza-
tion that TFF3 mRNA is present in the stomach from day 13 
of embryonic development. On days 15 and 16, TFF3 mRNA 
was observed from the stomach area to colon, and from day 17 
it was confined to the small intestine and colon [35]. However, 
our study showed a weak signal and uneven distribution of 
TFF3 peptide in the gastric and intestinal epithelium in E14 
and E15 stages, which could be due to the fact that the differ-
entiation of endoderm into intestinal epithelium occurred on 
the day 15 or 16 of embryonic development [36]. This is why 
the presence of TFF3 peptide was the most pronounced in 
E17 and E18 stages. Nevertheless, the fact that TFF3 peptide 
can be found to some extent in the gastrointestinal mucosa 
FIGURE 2. Trefoil factor family 3 (TFF3) peptide in different embry-
onic epithelial tissues. (A) Presence of TFF3 peptide in the nasal 
respiratory epithelium; 16-day-old mouse. (B) Developing lungs of 
a 14-day-old mouse embryo devoid of any TFF3 immunostaining. 
(C) Respiratory epithelium in the bronchioles of a 17-day-old mouse 
embryo positive for TFF3 peptide. (D) Localization of TFF3 peptide in 
the kidney of a 17-day-old mouse embryo. TFF3 peptide is present 
in the cortical tubules (arrow heads) and in the medullary tubules 
as well (arrow). Glomeruli (black circle) and the developing tubular 
structures of the nephrogene zone (white circle) are negative for 
TFF3 peptide. (E) Mild TFF3 staining in the developing epidermis 
of a 15-day-old mouse embryo. (F) Epidermal signal confined to 
stratum granulosum and stratum spinosum of a 17-day-old mouse 
embryo. (G) Developing eye in a 15-day-old mouse embryo. The 
signal is visible in the cornea (arrow head) and in the lens (arrow). 
(H) Inner ear in a 17-day-old mouse embryo. TFF3 is present in the 
cochlear epithelium (arrow heads). Spiral ganglion is also positive 
(arrows). Scale bar: (A), (E), (F) – 60 µm, (B), (C), (D), (G), (H) – 100 µm.
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before the maturation of the epithelium raises questions 
regarding its possible role in the differentiation of the main 
cell lines in this mucosa, since the similar role of TFF1 peptide 
was already described in gastric epithelium [37,38]. Having in 
mind the timeframe of TFF3 mRNA expression and peptide 
presence in the epithelium of the gastrointestinal tract, it may 
be hypothesized that TFF3 peptide contributes to the differ-
entiation of endoderm to mature epithelium. Nevertheless, 
since no characteristic cell differentiation disorder is reported 
for TFF3 knockout mice, we can assume that TFF3 peptide 
is not crucial for this process. TFF3 peptide was observed in 
the goblet cells as soon as the epithelium was differentiated, 
and this finding supports the notion that it is an early marker 
of gastrointestinal maturation [33]. TFF3 peptide was also 
present on the mucosal surface and in the scarce intestinal 
content. Considering its effects on cytokines and defensin 
expression [13], TFF3 peptide might contribute to the mech-
anisms of innate immunity and mucosal protection. TFF3 
signal found in the embryonic pancreas correlates with what 
is currently known about its localization in adult pancreas tis-
sue, where it is found in the pancreatic islets and ducts [39]. It 
is still unclear if TFF3 peptide is involved in the development 
of pancreas. Similarly, the role of TFF3 peptide in the tooth 
development is also not understood well, and this should be 
investigated in the future.
Our results showed that TFF3 signal coincided with the 
appearance of the goblet cells in the epithelium of the con-
ducting zone, including the nasal cavity. Mild signal intensity 
for TFF3 peptide was observed in several sections before the 
respiratory epithelium was fully differentiated (E14 and E15 
stages). Apart from the goblet cells, TFF3 peptide was located 
on the surface of respiratory epithelium, particularly in the 
area covered by the cilia. Previous research demonstrated that 
TFF3 peptide is associated with the differentiation of respira-
tory epithelium cells [8], and our results possibly confirm this 
role. A role of TFF3 peptide as a marker of mucosal matura-
tion is also plausible.
The TFF3 signal was strong in the tubular system of the 
developing kidney from the embryonic day 15, when mesone-
phric tubules were developed to some degree. Furthermore, 
no signal was detected in the nephrogenic zone where mes-
enchymal-epithelial transition (MET) takes place. This implies 
that TFF3 peptide has no effect on the MET, nor on the cell 
differentiation in kidney tubules. The occurrence of TFF3 pep-
tide in the later stages of kidney development might point to 
a role of TFF3 peptide in the functional maturation of tubu-
lar cells, or it could be simply used as a marker of epithelial 
maturation.
The epidermal stratification in mouse embryos starts 
around the 15th  day of embryonic development [40]. Our 
results revealed the presence of TFF3 peptide from day 14 to 
18 of embryonic development. As soon as the epidermis was 
stratified, TFF3 peptide was observed in the spinous layer, the 
place of proliferation and functional changes of keratinocytes, 
and in the granular layer, in which the nuclei and organelles are 
starting to disappear and keratohyalin is being accumulated. 
Although TFF3 peptide is not found in the adult skin [11], 
it might have a role in the differentiation of epidermal cells, 
but not a crucial one, since no skin abnormalities have been 
reported in TFF3 knockout mice. Because TFF1 and TFF3 
peptides are present in at least one type of skin cancer [41], the 
association between TFF3 peptide, embryonic development, 
and cancer pathogenesis might exist.
The presence of TFF3 peptide in the corneal epithelium of 
mouse embryo is in line with its role in the maintenance and 
repair of the ocular surface epithelium [12]. Although it was not 
a primary aim of this research, we also observed TFF3 signal 
in the structures of neural origin, namely, the retina and optic 
nerve. Since only TFF2 expression has been reported in the 
retina so far [42], it would be interesting to further investigate 
the expression of TFF3 peptide in this context, to determine 
if this was only a transient expression. TFF3 peptide has been 
detected in the inner ear, and it is important for normal hear-
ing [10,43]. It is possible that TFF3 peptide contributes to the 
normal development of the epithelial structures in the eye and 
ear. TFF3 peptide presence in the cochlear ganglion and nerves 
might partly explain presbycusis in TFF3 knockout mice. On 
the other hand, TFF3 peptide could also be important for the 
maintenance and normal development of the cochlear epithe-
lium. Further research is needed to elucidate the role of TFF3 
peptide in the development and function of sensory organs.
FIGURE 3. Examples of control sections. (A) Positive control. Adult 
mouse small intestine mucosa clearly shows trefoil factor family 3 
(TFF3) peptide staining in the goblet cells. (B) Negative control 1. 
Adult mouse small intestine mucosa with primary antibody omit-
ted. All tissues are negative. (C) Negative control 2. The small intes-
tine of a TFF3 knockout mouse is negative for TFF3. (D) Colonic 
mucosa of a 17-day-old mouse embryo with primary antibody 
omitted. Arrow heads show goblet cells on all four images. Scale 
bar: 60 µm on all images.
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Somewhat contradictory opinions have been reported 
with regard to the beneficial and harmful effects of TFF pep-
tides in various healthy and diseased tissues. Although import-
ant in mucosal repair and protection and differentiation of cer-
tain cell lines, these peptides also seem to be important in the 
pathogenesis and advancement of different diseases. The very 
same mechanisms by which TFF peptides act favorably on the 
homeostasis and repair of tissues (e.g., the effect on migration, 
differentiation, apoptosis, angiogenesis, etc.) also seem to con-
tribute to the malignant potential of several types of cancer, 
their invasiveness and metastases. The presence and local-
ization of TFF3 peptide in the embryonic epithelial tissues 
described in this work support a balanced perspective on the 
biological roles of TFF3 and possibly other two peptides. Thus, 
TFF3 peptide might be used as a molecular “tool” in both nor-
mal physiological and pathological conditions. Furthermore, 
since tumors are known to exhibit properties similar to that of 
embryonic tissues, better understanding of TFF3 peptide role 
in embryonic development could improve the understanding 
of its role in tumor pathogenesis and advancement [32,44]. 
This might further explain why in certain tissues, such as carti-
lage and cornea, TFF3 peptide is expressed during embryonic 
development, disease or injury, but not in healthy adult tissue. 
Since it is widely expressed in embryonic tissues, the role of 
TFF3 peptide in embryonic development should be further 
investigated.
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